Zhonghua Wai Ke Za Zhi. 2023 Mar 1;61(3):187-195. doi: 10.3760/cma.j.cn112139-20221027-00464.
Although there are still controversies over the efficiency and safety of minimally invasive radical surgery for pancreatic ductal adenocarcinoma (PDAC), most available studies have suggested a promising application of minimally invasive radical surgery. This consensus, referring to Chinese expert opinions and worldwide researches, aimed to discuss the related issues on minimally invasive radical surgery for PDAC to ensure the perioperative and oncological outcomes. Quality of evidence and strength of recommendations were evaluated based on the GRADE approach. The 15 recommendations covered 5 topics: oncological outcomes and patient safety of laparoscopic and robotic pancreatoduodenectomy, left-side pancreatectomy for PDAC, learning curve, safety of neoadjuvant therapy, and vascular resection in minimally invasive radical surgery for PDAC. This consensus gives reference and guidance to surgeons on the use of minimally invasive radical surgery for PDAC. Although this consensus is not sufficient to answer all the questions about minimally invasive radical surgery for PDAC, it represents the current consensus on the application of the techniques in the treatment of PDAC on the Chinese mainland.
尽管对于胰腺导管腺癌（PDAC）的微创根治性手术的效率和安全性仍存在争议，但大多数现有研究表明微创根治性手术具有广阔的应用前景。本共识参考中国专家意见和全球研究，旨在探讨PDAC微创根治性手术的相关问题，以确保围手术期和肿瘤学结局。基于GRADE方法评估证据质量和推荐强度。15条推荐涵盖5个主题：腹腔镜和机器人胰十二指肠切除术的肿瘤学结局和患者安全性、PDAC的左侧胰腺切除术、学习曲线、新辅助治疗的安全性以及PDAC微创根治性手术中的血管切除。本共识为外科医生使用PDAC微创根治性手术提供参考和指导。尽管本共识不足以回答关于PDAC微创根治性手术的所有问题，但它代表了中国大陆目前对该技术在PDAC治疗中应用的共识。
